Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study
- PMID: 20537493
- DOI: 10.1016/j.jacc.2010.04.012
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study
Abstract
Objectives: The purpose of this study was to investigate the 2-year outcome of percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) in patients with multivessel coronary artery disease (CAD).
Background: In patients with multivessel CAD undergoing PCI, coronary angiography is the standard method for guiding stent placement. The FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study showed that routine FFR in addition to angiography improves outcomes of PCI at 1 year. It is unknown if these favorable results are maintained at 2 years of follow-up.
Methods: At 20 U.S. and European medical centers, 1,005 patients with multivessel CAD were randomly assigned to PCI with drug-eluting stents guided by angiography alone or guided by FFR measurements. Before randomization, lesions requiring PCI were identified based on their angiographic appearance. Patients randomized to angiography-guided PCI underwent stenting of all indicated lesions, whereas those randomized to FFR-guided PCI underwent stenting of indicated lesions only if the FFR was <or=0.80.
Results: The number of indicated lesions was 2.7+/-0.9 in the angiography-guided group and 2.8+/-1.0 in the FFR-guided group (p=0.34). The number of stents used was 2.7+/-1.2 and 1.9+/-1.3, respectively (p<0.001). The 2-year rates of mortality or myocardial infarction were 12.9% in the angiography-guided group and 8.4% in the FFR-guided group (p=0.02). Rates of PCI or coronary artery bypass surgery were 12.7% and 10.6%, respectively (p=0.30). Combined rates of death, nonfatal myocardial infarction, and revascularization were 22.4% and 17.9%, respectively (p=0.08). For lesions deferred on the basis of FFR>0.80, the rate of myocardial infarction was 0.2% and the rate of revascularization was 3.2 % after 2 years.
Conclusions: Routine measurement of FFR in patients with multivessel CAD undergoing PCI with drug-eluting stents significantly reduces mortality and myocardial infarction at 2 years when compared with standard angiography-guided PCI. (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation [FAME]; NCT00267774).
Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
The impact of age on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) trial substudy.Int J Cardiol. 2014 Nov 15;177(1):66-70. doi: 10.1016/j.ijcard.2014.09.010. Epub 2014 Sep 20. Int J Cardiol. 2014. PMID: 25499342 Clinical Trial.
-
Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease.Circulation. 2010 Dec 14;122(24):2545-50. doi: 10.1161/CIRCULATIONAHA.109.925396. Epub 2010 Nov 29. Circulation. 2010. PMID: 21126973 Clinical Trial.
-
Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary revascularization in patients with small-vessel disease.Circ Cardiovasc Interv. 2012 Feb 1;5(1):62-8. doi: 10.1161/CIRCINTERVENTIONS.111.966937. Epub 2012 Feb 7. Circ Cardiovasc Interv. 2012. PMID: 22319067
-
Should we be using fractional flow reserve more routinely to select stable coronary patients for percutaneous coronary intervention?Curr Opin Cardiol. 2012 Nov;27(6):675-81. doi: 10.1097/HCO.0b013e328358f587. Curr Opin Cardiol. 2012. PMID: 23044917 Review.
-
Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease. A meta-analysis on 24,268 patients.Eur J Cardiothorac Surg. 2009 Oct;36(4):611-5. doi: 10.1016/j.ejcts.2009.03.012. Epub 2009 Apr 25. Eur J Cardiothorac Surg. 2009. PMID: 19394857 Review.
Cited by
-
Coronary pressure-derived fractional flow reserve in the assessment of coronary artery stenoses.Eur Radiol. 2013 Apr;23(4):958-67. doi: 10.1007/s00330-012-2670-4. Epub 2012 Nov 24. Eur Radiol. 2013. PMID: 23179519 Review.
-
Role of Fractional-Flow Reserve in Guiding Percutaneous Revascularization in Stable Coronary Artery Disease.Curr Atheroscler Rep. 2015 Sep;17(9):52. doi: 10.1007/s11883-015-0530-9. Curr Atheroscler Rep. 2015. PMID: 26202795 Review.
-
Clinical applications of fractional flow reserve in bifurcation lesions.J Geriatr Cardiol. 2012 Sep;9(3):278-84. doi: 10.3724/SP.J.1263.2012.05091. J Geriatr Cardiol. 2012. PMID: 23097658 Free PMC article.
-
The impact of coronary microvascular dysfunction on the discordance between fractional flow reserve and resting full-cycle ratio in patients with chronic coronary syndromes.Front Cardiovasc Med. 2022 Oct 5;9:1003067. doi: 10.3389/fcvm.2022.1003067. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36277746 Free PMC article.
-
Less Money, Less Problems: Real-World Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention.JACC Adv. 2022 Nov 30;1(5):100146. doi: 10.1016/j.jacadv.2022.100146. eCollection 2022 Dec. JACC Adv. 2022. PMID: 38939461 Free PMC article.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous